Related Experiment Video
Updated: May 5, 2026

11:49
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
15.5K
Donor-associated malignancy in kidney transplant patients
1Department of Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599, USA.
The Journal of Clinical Investigation
|August 28, 2013
Summary
Donor-derived skin cancer cells were found in a kidney transplant recipient, suggesting donor DNA can contribute to recipient malignancy. This finding impacts cancer research and patient care.
Area of Science:
- Oncology
- Transplantation immunology
- Dermatology
Background:
- Donor-derived DNA is detectable in recipients of allogeneic transplants.
- The role of donor genotype in recipient epithelial malignancies, particularly skin cancer, is not well understood.
Purpose of the Study:
- To investigate the potential contribution of donor cells to the development of skin squamous cell carcinoma in a kidney transplant recipient.
Main Methods:
- Case report analysis.
- Genotyping of recipient and donor DNA in tumor tissue.
- Histopathological examination of skin lesions.
Main Results:
- Evidence of donor genotype in the malignant epithelial cells of a skin squamous cell carcinoma was identified in a kidney transplant recipient.
- This represents the first documented case of donor contribution to recipient skin cancer.
Conclusions:
- Donor cells can contribute to the development of malignant epithelium in transplant recipients.
- This finding has significant implications for understanding cancer development in immunocompromised patients.
- Further research is warranted to explore the clinical significance and mechanisms of donor-driven carcinogenesis in transplant recipients.
Related Concept Videos
Bone Marrow Sampling and Transplants
3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Kidney Transplant II: Surgical Procedure
926
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
926
Kidney Transplant III: Nursing Management
631
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
631

